Skip to main content

Published locations for FDA approves dabrafenib and trametinib for BRAF V600E+ metastatic NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves dabrafenib and trametinib for BRAF V600E+ metastatic NSCLC

User login

  • Reset your password
  • /content/fda-approves-dabrafenib-and-trametinib-braf-v600e-metastatic-nsclc
  • /oncologypractice/article/141129/lung-cancer/fda-approves-dabrafenib-and-trametinib-braf-v600e
  • /node/155702/article/141129/lung-cancer/fda-approves-dabrafenib-and-trametinib-braf-v600e-metastatic
  • /hematology-oncology/article/141129/lung-cancer/fda-approves-dabrafenib-and-trametinib-braf-v600e
  • /chestphysician/article/141129/lung-cancer/fda-approves-dabrafenib-and-trametinib-braf-v600e